Jewish 100, 2014: Ephrat Levy-Lahad – Innovation and Activism
×
Error: Contact form not found.
by Algemeiner Staff
Ephrat Levy-Lahad
Medical researcher
All women of Ashkenazi origin should be screened for two breast-cancer predisposition genes from the age of 30, said Prof. Ephrat Levy-Lahad, the head of a leading research team at Shaare Zedek Medical Center. Levy-Lahad’s 2014 announcement, which received international attention, was a departure from the previous guideline of testing for the two BRCA genes only if a close blood relative contracted breast or ovarian cancer. The finding will likely change screening practices in Israel and in Jewish communities worldwide, ultimately saving lives.
103 House Democrats Back Measure Their Own Whip Said Could Cut Aid to Palestinians
Jewish Advocacy Group Blasts Australian Higher Education Establishment Over Antisemitism Revelations
Violent Antisemitic Attacks Skyrocket Across Canada, Putting 2026 on Track for Record Year
Israeli Tourist Reportedly Refused Service in Athens Amid Rising Anti-Israel Hostility
NYTimes Shareholder Threatens Lawsuit Over Publication’s Alleged Anti-Israel Biased Coverage
History Doesn’t Begin With Hate; It Begins With Silence
Hamas Is Still Using Hospitals as Terror Bases
I Want to Become a Journalist — But I Don’t See Israel Being Treated Fairly on Campus
Rep. Ro Khanna Pressed to Support Oct. 7 in Interview with Pro-Hamas News Outlet
UK Upholds ICC Prosecutor Karim Khan’s Suspension Over Sexual Misconduct Allegations






NYTimes Shareholder Threatens Lawsuit Over Publication’s Alleged Anti-Israel Biased Coverage
103 House Democrats Back Measure Their Own Whip Said Could Cut Aid to Palestinians
I Want to Become a Journalist — But I Don’t See Israel Being Treated Fairly on Campus
Hamas Is Still Using Hospitals as Terror Bases
History Doesn’t Begin With Hate; It Begins With Silence



